000 03812naa a22005297i 4500
001 UMUN-OA-20261005-MLS-053
003 local
005 20261005174905.0
006 m o d
007 cr||||||||||||
008 261005s2022 xx o u000 0 eng d
024 7 _a10.3343/alm.2022.42.1.3
_2doi
035 _a(local)EuropePMC:PMC8368230
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aKhaldoun Ghazal
_eauthor.
245 1 0 _aHormone Immunoassay Interference: A 2021 Update. /
_cKhaldoun Ghazal; Severine Brabant; Dominique Prie [and others].
264 1 _a[Place of publication not identified] :
_bKorean Society for Laboratory Medicine,
_c2022.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aImmunoassays are powerful qualitative and quantitative analytical techniques. Since the first description of an immunoassay method in 1959, advances have been made in assay designs and analytical characteristics, opening the door for their widespread implementation in clinical laboratories. Clinical endocrinology is closely linked to laboratory medicine because hormone quantification is important for the diagnosis, treatment, and prognosis of endocrine disorders. Several interferences in immunoassays have been identified through the years; although some are no longer encountered in daily practice, cross-reaction, heterophile antibodies, biotin, and anti-analyte antibodies still cause problems. Newer interferences are also emerging with the development of new therapies. The interfering substance may be exogenous (e.g., a drug or substance absorbed by the patient) or endogenous (e.g., antibodies produced by the patient), and the bias caused by interference can be positive or negative. The consequences of interference can be deleterious when clinicians consider erroneous results to establish a diagnosis, leading to unnecessary explorations or inappropriate treatments. Clinical laboratories and manufacturers continue to investigate methods for the detection, elimination, and prevention of interferences. However, no system is completely devoid of such incidents. In this review, we focus on the analytical interferences encountered in daily practice and possible solutions for their detection or elimination.
540 _aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by-nc/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aImmunoassay
650 4 _aHormone
650 4 _ainterference
650 4 _abiotin
650 4 _aHeterophile Antibodies
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aimmunoassay
655 4 _aReview articles.
700 0 _aSeverine Brabant
_eauthor.
700 0 _aDominique Prie
_eauthor.
700 0 _aMarie-Liesse Piketty
_eauthor.
773 0 _tAnnals of laboratory medicine
_gVol. 42, no. 1, (2022), pages/article 3-23
_x2234-3806
856 4 0 _uhttps://europepmc.org/articles/PMC8368230
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC8368230
_qlocal
942 _n0
999 _c1195
_d1195